Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
104 studies found for:    Open Studies | "Dry Eye Syndromes"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Dry Eye Syndromes"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
Condition: Dry Eye Syndrome
Interventions: Drug: RGN-259;   Drug: Placebo
2 Recruiting Effect of Nursing Care on Prevention of Dry Eye
Condition: Dry Eye Syndromes
Interventions: Device: LACRIBELL®;   Device: VIDISIC® GEL
3 Recruiting Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: AGN-195263;   Drug: Vehicle
4 Recruiting Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: AGN-195263;   Drug: Vehicle
5 Recruiting Safety and Efficacy of TOP1630 for Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Drug: TOP1630 Ophthalmic Solution;   Drug: Placebo to TOP1630 Ophthalmic Solution
6 Recruiting Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome
Condition: Dry Eye Syndrome
Interventions: Drug: HU00701;   Drug: HU007;   Drug: Restasis;   Drug: Placebo
7 Recruiting Walnut Shell Glasses Moxibustion for Dry Eye Syndrome
Condition: Dry Eye
Interventions: Procedure: Walnut Shell Glasses Moxibustion;   Drug: Sodium hyaluronate eye drops
8 Not yet recruiting Safety and Efficacy of BRM421 for Dry Eye Syndrome
Condition: Dry Eye Syndrome
Intervention: Drug: BRM421
9 Not yet recruiting Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction
Condition: Dry Eye Syndrome
Interventions: Device: intense pulsed light;   Drug: Tobramycin and Dexamethasone Ophthalmic Ointment
10 Not yet recruiting Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients
Condition: Dry Eye Syndromes
Interventions: Drug: Prosicca;   Drug: Prosicca sine;   Other: Bacterial culture
11 Not yet recruiting A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: Omega 3;   Drug: Optive Advanced;   Drug: Optive
12 Recruiting Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
Condition: Dry Eye
Interventions: Drug: Liposic;   Drug: Tears Naturale Forte
13 Recruiting Lamelleye vs Comparator for the Treatment of Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Device: Lamelleye Dry Eye Drops;   Device: Optive Plus
14 Recruiting DNase Treatment for Dry Eyes
Condition: Dry Eye
Interventions: Drug: DNase;   Drug: Vehicle
15 Recruiting Study to Evaluate the Efficacy and Safety of CKD-350
Condition: Dry Eye Syndrome
Interventions: Drug: Xenobella;   Drug: Isotonic 0.3% Sodium Hyaluronate
16 Recruiting 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients
Conditions: Dry Eye Syndromes;   Diabetes Mellitus
Intervention: Drug: 0.3% Sodium Hyaluronate
17 Recruiting Evaluation of Dry Eye by Tear Film Imager in a Low Humidity Environmental Exposure Chamber (TFI-LH16)
Condition: Dry Eye
Interventions: Diagnostic Test: Tear Film Imager;   Diagnostic Test: Low Humidity Environmental Exposure Chamber (LH-EEC)
18 Recruiting Safety and Efficacy of KPI-12 in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: KPI-121 0.25% Ophthalmic Suspension;   Drug: Vehicle of KPI-121 0.25% Ophthalmic Suspension
19 Recruiting Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: KPI-121 0.25% Ophthalmic Suspension;   Drug: Vehicle of KPI-121 0.25% Ophthalmic Suspension
20 Recruiting Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis?
Condition: Dry Eye
Interventions: Drug: Pregabalin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.